ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: BCR-ABL activates downstream signal transduction pathways, thereby regulates the expression of cytokines, further leading to immature myeloid cells release into the peripheral blood, that is, occurrence of CML (3).